We think Raccoon’s valuation could course correct very soon as the company’s impressive performance during COVID was mostly driven by temporary factors like demand for masks and sterilization products
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.